The Venture Codex Logo

The Venture Codex

New Day Fund

7 Handyside Street, London, N1C, 4DA, United Kingdom

Overview

NewDay, formerly SAV Credit, is a financial services company specialising in providing credit products to consumers in the United Kingdom. Their vision is straightforward, to help people be better with credit. This is powered by their Manifesto. Their Manifesto is made up of four core principles, we’re a welcoming, understanding, knowing and rewarding business. They make their Manifesto meaningful by placing their customers at its heart, and their Manifesto at the heart of their business strategy. It’s as simple as that.

Total investments
1
Lead investments
0
Investments · 12mo
0
Active investors
8

Sector focus

  • Banking
  • Financial Services
  • FinTech
Visit website

Investment portfolio

  • Minghui Pharmaceutical

    Participated · Equity · Aug 2025

    Minghui Pharmaceutical is a late-stage clinical biopharmaceutical company led by CEO Dr. Guoqing Cao, focused on developing new medicines for oncology and immunology. The company leverages proprietary technology platforms to build a differentiated pipeline of novel therapies. Its clinical priorities include a PD-1/VEGF bispecific antibody and combination strategies with antibody-drug conjugates (ADCs). Minghui also plans a commercial launch of a topical JAK inhibitor in China. The company intends to use new financing to advance its clinical programs and support the planned product launch. Headquarters are in Singapore.

Team

  • John Hourican

    Executive Director and Chief Executive Officer

  • Melchee Johnson

    Founder

    LinkedIn
  • Mark Eyre

    Chief Risk Officer

    LinkedIn
  • Rupert Keeley

    Non-Executive Director, NewDay Group Ltd